Jin Yang Pharmaceutical Co., Ltd. (KOSDAQ:007370)

Jin Yang Pharmaceutical Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 14, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	79,112	66,504	66,805	70,257	78,689	78,242
Market Cap Growth	4.71%	-0.45%	-4.91%	-10.72%	0.57%	59.09%
Enterprise Value	152,808	148,150	73,349	78,626	79,706	80,961
Last Close Price	6600.00	5820.00	6033.16	6200.80	6545.23	6413.17
PE Ratio	2.61	2.24	5.41	5.71	8.25	14.96
PS Ratio	0.68	0.59	0.71	0.92	1.25	1.58
PB Ratio	0.64	0.56	0.75	0.91	1.21	1.62
P/TBV Ratio	0.67	0.58	0.80	0.95	1.24	1.67
P/FCF Ratio	-	-	8.51	16.61	-	16.03
P/OCF Ratio	5.19	5.20	7.83	9.43	39.93	12.53
EV/Sales Ratio	1.31	1.31	0.78	1.03	1.27	1.64
EV/EBITDA Ratio	10.01	10.79	6.47	5.86	8.74	12.83
EV/EBIT Ratio	11.45	12.65	8.45	7.06	11.45	19.00
EV/FCF Ratio	-2.04	-	9.34	18.59	-	16.59
Debt / Equity Ratio	0.63	0.67	0.09	0.26	0.31	0.13
Debt / EBITDA Ratio	5.11	5.80	0.69	1.49	2.20	0.97
Debt / FCF Ratio	-	-	1.00	4.72	-	1.26
Asset Turnover	0.66	0.65	0.80	0.72	0.74	0.71
Inventory Turnover	2.70	2.72	2.24	2.50	3.41	3.19
Quick Ratio	1.72	1.44	1.24	0.98	1.16	1.11
Current Ratio	2.58	2.19	1.96	1.50	1.51	1.55
Return on Equity (ROE)	28.24%	28.46%	14.84%	17.23%	16.79%	11.38%
Return on Assets (ROA)	4.71%	4.21%	4.63%	6.54%	5.12%	3.81%
Return on Capital (ROIC)	5.48%	4.94%	5.59%	7.61%	6.23%	4.96%
Return on Capital Employed (ROCE)	6.30%	5.60%	9.10%	13.30%	9.80%	8.00%
Earnings Yield	38.04%	44.65%	18.47%	17.52%	12.12%	6.68%
FCF Yield	-94.76%	-116.19%	11.75%	6.02%	-0.69%	6.24%
Payout Ratio	5.38%	5.45%	13.10%	9.08%	11.72%	21.38%
Buyback Yield / Dilution	5.33%	1.17%	7.18%	-17.77%	-2.12%	-

Updated Mar 1, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.